Temsirolimus

Chemical formula: C₅₆H₈₇NO₁₆  Molecular mass: 1,030.287 g/mol  PubChem compound: 23724530

Therapeutic indications

Temsirolimus is indicated for:

Renal cell carcinoma

Population group: only adults (18 years old or older)

Temsirolimus is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Mantle cell lymphoma

Population group: only adults (18 years old or older)

Temsirolimus is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (MCL).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Temsirolimus is contraindicated in the following cases:

Moderate or severe hepatic impairment

at least one of
Hepatic failure stage III
Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: TORISEL Concentrate and solvent for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈